Search Results for "13"

Code for modeling estimated deaths and infections for COVID-19 from "Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe", Flaxman, Mishra, Gandy et al, Nature, 2020, the published version of our original Report 13. This is the release related to our Tiers paper, where we use the latent factor model to estimate the effectiveness of tiers systems in England. Peer-reviewed version is to be out soon. All other code is still the same for previous releases. The code...

Dissolution profile comparison (Biowaiver aid) Model Dependent-Independent Approach scripts for in-vitro dissolution profile comparison as proposed by Sathe et al. in 1996 (Sathe PM, Tsong Y, Shah VP. In-vitro dissolution profile comparison: statistics and analysis, model dependent approach. Pharm Res. 1996 Dec;13(12):1799-803) and Tsong et al. in 1996 (Tsong Y, Hammerstrom T, Sathe P, Shah VP. (1996) Statistical Assessment of Mean Differences between Two Dissolution Data Sets, Drug Info. J. 30...

... before upgrading. Also check the files section for: - The "No Administrator Rights" install version. - Portable ZIP version. - The source code. 2014-12-13 version 1.6: Check blog for changelog. Would you like to translate MedRec to your own language? Then check the translation tool in the source code zip file. You can also share the lang. XML file after in the discussion forum! Are there missing features you would like to see in MedRec? Leave a suggestion in the discussion forum!

.... The exemplary results show cross-sectional as well as longitudinal variations and may indicate a first step for the course of action in terms of health care politics, hospital management and quality of health care provision. Empirical grounds for a debate of further quality improvements should be given. The method can be adopted for every other illness with disease phases. Users should be aware of method’s pitfalls and weaknesses (see Jacke et al BMC Public Health 2013, 13:34).